UNSPSC 51372501: Metheptazine

This classification denotes an opioid receptor agonist with the molecular formula C16H23NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 93X4R66P5A, chemically known as methyl 1,2-dimethyl-4-phenyl-4-azepanylcarboxylat but generally known as metheptazine, which bears US NIH Compound Identifier 3047717. European Medicines Agency schedules Metheptazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08846MIG. The term METHEPTAZINE is an International Non-Proprietary Name.

UNSPSC 51372501 Metheptazine is a Commodity code nominally aligned with pharmaceutical products, though the recent state and local procurement activity under this code does not reflect metheptazine procurement. The only recent opportunity on record—Seminole County, Florida's IFB60459723LAS posted June 30, 2026—solicits naloxone and drug deactivation systems for community health initiatives, which falls outside the scope of the metheptazine commodity itself. The code shows little relevant recent activity aligned with its nominal pharmaceutical classification.

Seminole County released the IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually through an electronic bidding process, with a response deadline of July 26, 2023, at 2:00 pm. The contract includes quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with vendors responsible for all shipping and delivery costs. The initial award runs two years with an optional one-year renewal on a fixed-fee basis; contractors must comply with drug-free workplace certification, E-Verify requirements, and maintain workers' compensation, commercial general liability, and professional liability insurance. The procurement was potentially funded through FEMA, introducing additional compliance requirements under the Clean Air Act and Federal Water Pollution Control Act.